Schedule of Warrant Activity (Details) - USD ($) |
5 Months Ended | 6 Months Ended |
|---|---|---|
Oct. 31, 2025 |
Oct. 31, 2025 |
|
| Share-Based Payment Arrangement [Abstract] | ||
| Number of Warrants,Outstanding | ||
| Weighted Average Exercise Price, Outstanding | ||
| Aggregate Intrinsic Value, Outstanding | ||
| Number of Warrants,Granted | 6,930,697 | |
| Weighted Average Exercise Price, Granted | $ 1.46 | |
| Number of Warrants,Exercised | 119,535 | 2,376,236 |
| Weighted Average Exercise Price, Exercised | ||
| Number of Warrants,Forfeited | ||
| Number of Warrants,Expired | ||
| Number of Warrants,Outstanding | 4,554,461 | 4,554,461 |
| Weighted Average Exercise Price,Outstanding | $ 2.22 | $ 2.22 |
| Aggregate Intrinsic Value, Exercisable | $ 26,447,530 | $ 26,447,530 |
| Number of Warrants,Exercisable | 4,554,461 | 4,554,461 |
| Weighted Average Exercise Price, Exercisable | $ 2.22 | $ 2.22 |
| X | ||||||||||
- Definition Class of warrant or right exercisable warrants or rights 1 No definition available.
|
| X | ||||||||||
- Definition Class of warrant or right outstanding aggregate intrinsic value No definition available.
|
| X | ||||||||||
- Definition Class of warrant or right weighted average exercise price exercised No definition available.
|
| X | ||||||||||
- Definition Class of warrant or right weighted average exercise price granted No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercisable number No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|